Contribution of intronic miR-338–3p and its hosting gene AATK to compensatory β-cell mass expansion

Molecular Endocrinology

Volumn 29, Issue 5, 2015, Pages 693-770

  Jacovetti, Cécile ^a   Jimenez, Veronica ^b,c   Ayuso, Eduard ^b,c,f,g   Laybutt, Ross ^d   Peyot, Marie Line ^e   Prentki, Marc ^e   Bosch, Fatima ^b,c   Regazzi, Romano ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d ST VINCENT S HOSPITAL   (Australia)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS ASSOCIATED TYROSINE KINASE; CYCLIC AMP; ESTRADIOL; EXENDIN 4; MESSENGER RNA; MICRORNA; MICRORNA 338 3P; PARVOVIRUS VECTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; AATK PROTEIN, RAT; APOPTOSIS REGULATORY PROTEIN; MIRN338 MICRORNA, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL EXPANSION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN RELEASE; INSULIN RESISTANCE; INTRON; LUCIFERASE ASSAY; MALE; NONHUMAN; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ANIMAL; CELL LINE; GENETICS; PHYSIOLOGY; WISTAR RAT;

ANIMALIA; MUS; RATTUS; RODENTIA;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CELL PROLIFERATION; ESTRADIOL; FEMALE; INSULIN-SECRETING CELLS; MALE; MICRORNAS; PROTEIN-TYROSINE KINASES; RATS, WISTAR; RNA INTERFERENCE;

EID: 84930513535     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1299     Document Type: Article

References (41)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.
2. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microR NAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835–840.
3. Eliasson L, Esguerra JL. Role of non-coding RNAs in pancreatic -cell development and physiology. Acta Physiol (Oxf). 2014;211: 273–284.
4. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res. 2011;157:253–264.
5. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14:1902–1910.
6. Kim VN, Nam JW. Genomics of microRNA. Trends Genet. 2006; 22:165–173.
7. Li SC, Tang P, Lin WC. Intronic microRNA: discovery and biological implications. DNA Cell Biol. 2007;26:195–207.
8. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA. 2005;11:241–247.
9. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One. 2009;4:e5279.
10. Jacovetti C, Abderrahmani A, Parnaud G, et al. MicroRNAs contribute to compensatory  cell expansion during pregnancy and obesity. J Clin Invest. 2012;122:3541–3551.
11. Barik S. An intronic microRNA silences genes that are functionally antagonistic to its host gene. Nucleic Acids Res. 2008;36:5232– 5241.
12. Gaozza E, Baker SJ, Vora RK, Reddy EP. AATYK: a novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells. Oncogene. 1997;15:3127–3135.
13. Baker SJ, Sumerson R, Reddy CD, Berrebi AS, Flynn DC, Reddy EP. Characterization of an alternatively spliced AATYK mRNA: expression pattern of AATYK in the brain and neuronal cells. Oncogene. 2001;20:1015–1021.
14. Tomomura M, Hasegawa Y, Hashikawa T, et al. Differential expression and function of apoptosis-associated tyrosine kinase (AATYK) in the developing mouse brain. Brain Res Mol Brain Res. 2003;112:103–112.
15. Tomomura M, Morita N, Yoshikawa F, et al. Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family. Neuroscience. 2007;148:510–521.
16. Raghunath M, Patti R, Bannerman P, et al. A novel kinase, AATYK induces and promotes neuronal differentiation in a human neuroblastoma (SH-SY5Y) cell line. Brain Res Mol Brain Res. 2000;77: 151–162.
17. Ma S, Rubin BP. Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma. Lab Invest. 2014;94:430–438.
18. Kjørholt C, Akerfeldt MC, Biden TJ, Laybutt DR. Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of -cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes. 2005;54:2755–2763.
19. Peyot ML, Pepin E Lamontagne J, et al., -Cell failure in dietinduced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced -cell mass. Diabetes. 2010;59:2178–2187.
20. Gotoh M, Maki T, Satomi S, et al. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation. 1987;43: 725–730.
21. Ayuso E, Mingozzi F, Montane J, et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 2010;17:503–510.
22. Lock M, McGorray S, Auricchio A, et al. Characterization of a recombinant adeno-associated virus type 2 reference standard material. Hum Gene Ther. 2010;21:1273–1285.
23. Jimenez V, Ayuso E, Mallol C, et al. In vivo genetic engineering of murine pancreatic  cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9. Diabetologia. 2011;54: 1075–1086.
24. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007; 4:721–726.
25. Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA. 2010;16:2043–2050.
26. Faustman D, Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov. 2010;9:482–493.
27. Rieck S, Kaestner KH. Expansion of -cell mass in response to pregnancy. Trends Endocrinol Metab. 2010;21:151–158.
28. Terauchi Y, Takamoto I, Kubota N, et al. Glucokinase and IRS-2 are required for compensatory  cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest. 2007;117: 246–257.
29. Georgia S, Hinault C, Kawamori D, et al. Cyclin D2 is essential for the compensatory -cell hyperplastic response to insulin resistance in rodents. Diabetes. 2010;59:987–996.
30. Davis DB, Lavine JA, Suhonen JI, et al. FoxM1 is up-regulated by obesity and stimulates -cell proliferation. Mol Endocrinol. 2010; 24:1822–1834.
31. Cornu M, Modi H, Kawamori D, Kulkarni RN, Joffraud M, Thorens B. Glucagon-like peptide-1 increases -cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression. J Biol Chem. 2010;285: 10538–10545.
32. Cornu M, Yang JY, Jaccard E, Poussin C, Widmann C, Thorens B. Glucagon-like peptide-1 protects -cells against apoptosis by in creasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Diabetes. 2009;58:1816–1825.
33. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A Enright AJ., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34:D140–144.
34. Osokine I, Hsu R, Loeb GB, McManus MT. Unintentional miRNA ablation is a risk factor in gene knockout studies: a short report. PLoS Genet. 2008;4:e34.
35. Büning H, Perabo L, Coutelle O, Quadt-Humme S, Hallek M. Recent developments in adeno-associated virus vector technology. J Gene Med. 2008;10:717–733.
36. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002;16: 70–84.
37. Yu Z, Jin T. New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP1). Cell Signal. 2010;22:1–8.
38. Gokey NG, Srinivasan R, Lopez-Anido C, Krueger C, Svaren J. Developmental regulation of microRNA expression in Schwann cells. Mol Cell Biol. 2012;32:558–568.
39. Kos A, Olde Loohuis NF, Wieczorek ML, et al. A potential regulatory role for intronic microRNA-338–3p for its host gene encoding apoptosis-associated tyrosine kinase. PLoS One. 2012;7:e31022.
40. Li P, Chen X, Su L, et al. Epigenetic silencing of miR-338–3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. PLoS One. 2013;8:e66782.
41. Fu X, Tan D, Hou Z, Hu Z, Liu G. miR-338–3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3-UTR region of cyclinD1. Int J Mol Sci. 2012;13:8514–8539.